Hainan Kangzhe Aesthetics Technology

Hainan Kangzhe Aesthetics Technology is a subsidiary of China Medical System Holdings Limited focused on regenerative medical aesthetic products. The company has obtained exclusive licenses for several injectable fillers based on poly-L-lactic acid, polycaprolactone, and calcium hydroxyapatite. These products are designed as Class III medical devices for deep dermal or subcutaneous injection to correct moderate to severe facial wrinkles by stimulating collagen regeneration. As of early 2024, these products are undergoing clinical registration trials in China and have not yet reached commercial launch but are expected to enter the market following regulatory approval[5][6].